https://investor.ironwoodpharma.com/press-releases/press-release-details/2022/Ironwood-Presents-New-Data-Demonstrating-Potential-of-IW-3300-for-Visceral-Pain-at-Digestive-Disease-Week-DDW-2022/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- May 25, 2022